Features

Day 2 of DDL 22 started off with a focus on delivery devices, beginning with a talk by Professor Myrna Dolovich of McMaster University on selecting the correct device for patients and ending with a panel discussion between four "champions": Stephen Stein of 3M championing MDIs, David Harris of Team Consulting championing DPIs, Philippe Rogueda of Monash University … [Read more...] about DDL 22 — Day 2

Nearly 500 people attended the first day of the 2011 Drug Delivery to the Lungs meeting (DDL 22) at the Edinburgh International Conference Centre. Approximately 50 of the DDL 22 attendees were also registered for the ISAM workshop on lung imaging standardization which took place in the morning prior to the opening of the main conference. The meeting opened with an … [Read more...] about DDL 22 — Day 1

The upcoming Aerosols–Inhalation and Nasal Drug Products Workshop sponsored by the United States Pharmacopoeia’s General Chapters-Dosage Forms Expert Committee will take place at USP headquarters in Rockville, MD on December 12 and 13, and the organizers are expecting that up to 75 OINDP specialists from industry, academia, and regulatory agencies will … [Read more...] about The USP Aerosols–Inhalation and Nasal Drug Products Workshop

The 2011 Drug Delivery to the Lungs (DDL) Conference, which takes place December 7-9 in Edinburgh, UK, will highlight a particularly strong field of scientific presentations from both established industry experts and up-and-coming young researchers, according to DDL committee member and Treasurer, Mark Hammond. In addition, Hammond says, this year’s conference will … [Read more...] about DDL 22 provides scientific and networking opportunities for OINDP specialists

OINDP researchers with a particular interest in powder flow and rheology should take note that poster abstract submission and early registration for Powder Flow 2011 end on November 4. The meeting is organized by the Formulation Science and Technology Group of the Royal Society of Chemistry. Many of the members of the organizing committee have connections to the … [Read more...] about Powder Flow 2011 deadlines approaching

The 2011 annual meeting of the American Association of Pharmaceutical Scientists in Washington, DC, which took place from October 23-27, included presentations of research related to OINDPs in several formats: a pre-workshop on "Developing Pharmaceutical Products for Controlled Pulmonary Delivery"; a roundtable discussion titled, "QbD in Dry Powder Inhaler … [Read more...] about News from the 2011 AAPS annual meeting

Over the past few months, the US Health and Human Service Department’s Agency for Healthcare Research and Quality (AHRQ) has issued several statistical briefs and a research finding regarding rising expenditures for asthma medications used to treat children in the US. The researchers from AHRQ examined data from the 1997–2008 Medical Expenditure Panel Survey (MEPS) to … [Read more...] about Rise in ICS therapy for US children leads to huge increase in medication expenditures

Armstrong Pharmaceuticals, the manufacturer of the over-the-counter epinephrine MDI Primatene Mist, has been warning consumers to stock up on the product prior to its phaseout at the end of 2011, and now the US FDA is joining the effort to alert users of the inhaler. Primatene Mist is one of the last CFC inhalers marketed in the US to be phased out in conformance with … [Read more...] about FDA reaching out to Primatene Mist inhaler users in advance of phaseout

On or about September 6, 2011, United States District Court Judge William G. Young will hold a hearing to issue sanctions against InnovaSystems for contempt of court, having ruled that Innova has violated a permanent injunction against sales of its optical spray analyzing system. The hearing will be the latest milestone in a long-running legal dispute between … [Read more...] about Proveris Scientific Corp vs. InnovaSystems, Inc has some OINDP developers caught in the middle